1. Poland Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Mercator Medical SA

Mercator Medical SA

58.70
PLN
+0.60
(+1.03%)
1.27EPS
39.66P/E
470.96MMarket Cap
Nov 30Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
17.1
19.49
26.22
28.48
28.4
39.7
50.97
174.83
170.66
55.53
48.94
- -
62.27
62.18
Basic EPS, GAAP
0.79
1.16
1.19
1.5
0.47
0.72
-0.22
88.66
44.15
-19.41
-2.05
4.75
3.1
1.3
Free Cash Flow per Basic Share
-0.7
-1.58
-0.41
-0.38
-4.7
-4.84
2.17
66.43
32.23
-7.05
-4.09
-7.03
-1.46
1.6
Dividend per Share
0.02
0.03
0.25
- -
0.15
- -
- -
0.78
- -
- -
2.49
- -
- -
- -
Book Value per Share
6.22
7.46
8.41
11.53
11.17
12.01
12.57
99.79
117.07
103.24
88.23
99.02
98.88
100.39
Tangible Book Value per Share
6.22
7.44
8.17
11.28
10.93
11.71
12.22
99.42
116.08
100.7
84.84
99.02
95.85
97.45
Basic Weighted Avg Shares
9
9
9
9
11
11
11
10
10
10
10
9
9
9
Sales/Revenue/Turnover
148
168
227
264
301
420
540
1,834
1,727
543
469
- -
574
572
Operating Margin (%)
8.24
7.72
7.24
7.02
2.05
3.98
1.37
57.31
29.81
-13.53
-20.13
- -
-2.3
-0.56
Depreciation Expense
2
3
6
7
9
14
17
19
19
26
22
- -
29
30
Net Income, GAAP
7
10
10
14
5
8
-2
930
447
-190
-20
45
29
12
Effective Tax Rate (%)
18.98
15.99
2.8
12.82
10.39
13.51
198.16
10.09
6.78
- -
- -
- -
- -
37.45
Profit Margin (%)
4.65
5.95
4.53
5.27
1.64
1.82
-0.43
50.71
25.87
-34.95
-4.19
- -
4.98
2.09
Working Capital
27
26
36
54
38
31
38
856
781
638
507
- -
399
402
LT Debt
3
19
28
11
60
84
97
2
4
2
4
- -
18
17
Total Equity
57
64
73
123
120
128
134
1,043
1,145
1,009
860
918
901
915
Return on Invested Capital (%)
13.12
11.92
14.56
11.2
2.7
5.85
-2.49
131.66
37.17
- -
- -
-4.06
- -
0.12
Return on Capital (%)
11.81
12.01
10.74
10.14
3.2
5.13
-3.57
139.59
40.86
- -
- -
5.01
- -
1.37
Return on Common Equity (%)
18.38
16.95
14.98
14.28
4.1
6.23
-1.79
158.59
40.93
-17.62
-2.1
5.01
3.14
1.3

Capital Structure

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
4
5
6
LT Borrowings
- -
- -
- -
LT Finance Leases
20
18
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
403
347
471

Working Capital

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
555
494
500
Cash, Cash Equivalents & STI
203
200
204
Accounts Receivable, Net
83
100
96
Inventories
192
191
182
Total Current Liabilities
80
95
98
Payables & Accruals
- -
- -
- -
ST Debt
4
5
6
Deferred Revenue
- -
- -
- -

Growth Rates

PLN

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
74.26%
-2.39%
-1.8%
Free Cash Flow
388.67%
-45.69%
-79.62%
Net Income, GAAP
-4,080.77%
-129.35%
-35.94%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
131
123
139
- -
- -
2025
148
143
145
138
574
2026
146
- -
- -
- -
- -

Quarterly Earnings Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.19
-0.64
-2.83
- -
4.75
2025
3.18
-1.01
0.51
0.37
3.1
2026
1.44
- -
- -
- -
- -

Quarterly Dividends Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Monika Zyznowska
Full Time Employees
833
Sector
Distribution services
Industry
Medical distributors
Address
ul. Heleny Modrzejewskiej 30 Kraków MA Poland 31-327
IPO Date
Nov 21, 2013
Website
mercatormedical.eu
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Mercator Medical S.A. (MRC.WA) is a Poland-based manufacturer, distributor, and seller of single-use medical gloves and personal protective equipment for healthcare and industrial applications. The company offers a comprehensive portfolio of products including nitrile, latex, and vinyl examination gloves under its own brands such as NitraTouch, Dermagel, and Stronghold; surgical gloves; disposable protective clothing; face masks and respirators; disinfectants; and other medical consumables like swabs and dressings. These products cater to hospitals, clinics, laboratories, and industrial sectors, with distribution across Europe, Asia, Latin America, and North America. Founded in 1996 and headquartered in Krakow, Poland, Mercator Medical operates production facilities in Thailand, Malaysia, and China, enabling global supply chain efficiency and cost-competitive manufacturing. The company serves as a key supplier in the medical PPE sector, targeting both B2B clients such as wholesalers and healthcare providers, as well as end-users through its extensive logistics network. In recent developments, Mercator Medical expanded its production capacity through strategic investments in new glove manufacturing lines in Thailand in 2024, enhancing output amid sustained global demand for PPE; the company also formed distribution partnerships in emerging markets including Brazil and Mexico to bolster its presence in Latin America. Additionally, it completed a significant funding round via equity issuance on the Warsaw Stock Exchange in early 2025 to support facility upgrades and inventory buildup. No major acquisitions or name changes have been reported in the last two years, though the firm has shifted focus toward sustainable materials in glove production as part of its long-term operational strategy.